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Résumé en
anglais
Growing evidence suggests that hepatic-insulin resistance is sufficient to promote
progression to cardiovascular disease. We have shown previously that liver-specific
protein-tyrosine-phosphatase 1B (PTP1B) deficiency improves hepatic-insulin
sensitivity and whole-body glucose homeostasis. The aim of this study was to
investigate the impact of liver-specific PTP1B-deficiency (L-PTP1B−/−) on cardiac
and peripheral vascular function, with special emphasis on endothelial function in the
context of high-fat diet (HFD)-induced obesity.
L-PTP1B−/− mice exhibited an improved glucose and lipid homeostasis and
increased insulin sensitivity, without changes in body weight. HFD-feeding increased
systolic blood pressure (BP) in both L-PTP1B−/− and control littermates; however,
this was significantly lower in L-PTP1B−/− mice. HFD-feeding increased diastolic BP
in control mice only, whilst the L-PTP1B−/− mice were completely protected. The
analysis of the function of the left ventricle (LV) revealed that HFD-feeding decreased
LV fractional shortening in control animals, which was not observed in L-PTP1B−/−
mice. Importantly, HFD feeding significantly impaired endothelium-dependent
vasorelaxation in response to acetylcholine in aortas from control mice, whilst L-
PTP1B−/− mice were fully protected. This was associated with alterations in eNOS
phosphorylation. Selective inhibition of COX-2, using NS-398, decreased the
contractile response in response to serotonin (5-HT) only in vessels from control
mice. HFD-fed control mice released enhanced levels of prostaglandin E, a
vasoconstrictor metabolite; whilst both chow- and HFD-fed L-PTP1B−/− mice
released higher levels of prostacylin, a vasorelaxant metabolite.
Our data indicate that hepatic-PTP1B inhibition protects against HFD-induced
endothelial dysfunction, underscoring the potential of peripheral PTP1B inhibitors in
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